TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors

Cancer Research

Volumn 62, Issue 13, 2002, Pages 3587-3591

  Sinclair, Colleen S ^a   Adem, Camilo ^a   Naderi, Ali ^a   Soderberg, Cheryl L ^a   Johnson, Michele ^a   Wu, Kangjian ^a   Wadum, Linda ^a   Couch, Vicki L ^a   Sellers, Thomas A ^a   Schaid, Daniel ^a   Slezak, Jeffrey ^a   Fredericksen, Zach ^a   Ingle, James N ^a   Hartmann, Lynn ^a   Jenkins, Robert B ^a   Couch, Fergus J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENE PRODUCT; RSP6KB1 PROTEIN; TBX2 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER CONTROL; CHROMOSOME 17Q; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE GENE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; RPS6KB1 GENE; TBX2 GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, BRCA1; GENES, BRCA2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; T-BOX DOMAIN PROTEINS;

EID: 0036645397     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study
2. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
3. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
4. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis
5. MYB oncogene amplification in hereditary BRCA1 breast cancer
6. Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers
7. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors
8. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer
9. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
10. 17q23 amplifications in breast cancer involve the PATI, RAD51C, PS6K, and SIGMA1B genes
11. ARF) and is amplified in a subset of human breast cancers
12. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer
13. 1 progression
14. Efficacy of bilateral prophylactic mastectomy in BRCA1/2 mutation carriers
15. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization